Zimbabwe Launches Mass Drug Campaign Against Elephantiasis

Zimbabwe Launches Mass Drug Campaign Against Elephantiasis Zimbabwe has initiated a Mass Drug Administration (MDA) campaign targeting lymphatic filariasis, or elephantiasis, aiming to reach 1.4 million individuals across several districts. Running from September 16 to 28, 2024, the campaign utilized a new triple-drug therapy combining ivermectin, diethylcarbamazine, and albendazole, achieving a 73% coverage rate. Supported…